Publications To Date

    nCOUNTER PUBLICATIONS

    Filter Publications

    PAGE 8 OF 11 | DISPLAYING 106 - 120 OF 160 RESULTS

    Herter-Sprie G.S. et al., Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer, [Epub ahead of print]., JCI Insight, Jun 16, 2016

    Chen P.L. et al., Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade., [Epub ahead of print]., Cancer Discovery, Jun 14, 2016

    Mullane S.A. et. al., Correlation of Apobec Mrna Expression with overall Survival and pd-l1 Expression in Urothelial Carcinoma., [Epub ahead of print]., Sci. Reports, Jun 10, 2016

    Gray M.J. et al., Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers., [Epub ahead of print]., Breast Can Res., May 11, 2016

    De Marco P. et al., GPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response., [Epub ahead of print]., Sci. Reports, Apr 13, 2016

    Balko J. et al., Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence., [Epub ahead of print]., Sci. Transl. Med., Apr 13, 2016

    Sterman D.H. et al., PILOT AND FEASIBILITY TRIAL OF IMMUNO-GENE THERAPY OF MALIGNANT MESOTHELIOMA USING INTRAPLEURAL DELIVERY OF ADENOVIRUS- INTERFERON-ALPHA COMBINED WITH CHEMOTHERAPY., [Epub ahead of print]., Clin. Can. Res., Mar 11, 2016

    D'Artista L. et al., Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc., [Epub ahead of print]., Oncotarget, Mar 02, 2016

    Gabrusiewicz K et al., Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype, [Epub ahead of print]., JCI, Feb 25, 2016

    Peng W. et al., Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy., [Epub ahead of print]., Cancer Discovery, Feb 01, 2016

    Kroeger D.R. et al., Tumor infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T cell responses, and superior prognosis in ovarian cancer., [Epub ahead of print]., Clin. Cancer Res., Jan 13, 2016

    Vogelsang M. et al., The expression quantitative trait loci in immune pathways and their effect on cutaneous melanoma prognosis., [Epub ahead of print]., Clin. Can. Res., Jan 05, 2016

    Legrier M-E. et al., Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer., [Epub ahead of print]., Br. J. Cancer, Dec 22, 2015

    Sefert L. et al., Dectin-1 Regulates Hepatic Fibrosis and Hepatocarcinogenesis by Suppressing TLR4 Signaling Pathways, [Epub ahead of print]., Cell Reports, Nov 19, 2015

    Maxfield K.E. et al., Comprehensive functional characterization of cancer–testis antigens defines obligate participation in multiple hallmarks of cancer., [Epub ahead of print]., Nat. Commun., Nov 16, 2015